📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
52
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split
70%
• 50-day avg $0.07 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise
55%
• Critical: only 0.6 months cash remaining
📉 Score Deterioration
10%
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$41.76M
Shares Outstanding1.97B
Float673.12M
Cash$176.7K
Debt$530.0K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest357
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jan 31, 2026
xbrl
XBRL CONVERTIBLE
Jul 31, 2022
4
INSIDER TRANSACTION
Mar 06, 2026
4
INSIDER TRANSACTION
Mar 06, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CRSF
📊 CRSF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CRSF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.